Please enable JavaScript.
Coggle requires JavaScript to display documents.
12 Trends - (8 - Growth in Bio - China (Opportunity! (Enter market (Cease…
12 Trends -
8 - Growth in Bio - China
Bio - processing advances
Superior production capabilities
Advance in bio tech
Opportunity!
Enter market
Cease trend!
Buy exported biologics
Threat
Increased regulation
1 - Big Player Re-structure
Reduce
Resources
Pulling funding
Underperforming areas
Prioritise R&D
Adapt to opportunities/threats
Product decline
New biopharma
Conserve capital
To create new opportunities
4 - Budget pattern shift
Short term spending cuts
Affecting sustainability of off-patents
Withdrawal of meds
Costs V sustainablity
Pressure over prices
Reluctant to invest
In innovation
In maintaining off patents
10 - Industry-wide consolidation
M&A
Speciality services
Bolt-ons
And generics
3 - AI
Maturing
More known
More reliable
Increase data
Analytics
Predictive
inform decision making
Reduce waste
Increase speed of development
Real-time data
2 - M&A
Pharma/BioPharma
Cause
Increased demand for innovative medicines
Growing Aging population
With funds to buy
More drugs off patent
Consoidate
Complex chains
Outsourced
Simplify
Integrate
Cheap finance
5 - Value added - Digital healthcare
Challenges
showing value
To investors
Opportunities
Real-time data
Superior customer reaction
Partner with Tech expertise
11 - SuperGenerics
Shorter Development
Use of tech
Shorter REg processes
Quicker to market
Re-purposing
treat new conditions
Re-formulation
Differentiated
6 - industry 4.0 and Bio pharma
Challenges
Not tech savvy
Lack Knowledge/ experience
To implement
To integrate
With exiting systems
Lack of information
Best in class
Copy others
Will it add value?
7 - live cycle management
Brands
Willing to compete on price (effect)
Aggressive actions
Reliance on
Legacy products
Org capabilties
Cause
Red tape
Restricting growth
in other markets
Similar products available
9 - Understand patients needs
CDMO's evolution
Collaboraive partners
Incrase customer experience
TEch/tools
Excellence/Quality
Range of experiences
Add value for customers
Patient R&D
Understand needs
Smart enhancements
Strategic partnerships
Experienced
12 - rise in bio similars